# A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function

> **NCT02665039** · PHASE2 · COMPLETED · sponsor: **Dr Anders Ullén** · enrollment: 62 (actual)

## Conditions studied

- Urothelial Carcinoma
- Bladder Cancer
- Renal Pelvis Cancer
- Ureter Cancer
- Urethra Cancer

## Interventions

- **DRUG:** Vinflunine
- **DRUG:** Gemcitabine
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02665039
- **Lead sponsor:** Dr Anders Ullén
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2019-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02665039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02665039, "A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02665039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*